![]() 11 Specifically, the prevalence varied from 13.3 percent to 65.4 percent in high myopes, 0.3 percent to 7.8 percent in moderate myopes, and 0.1 percent to 7.0 percent in low myopes. Prevalence The prevalence of MM ranged from 0.2 percent to 4.0 percent in myopic patients. These most recent findings on MM review its prevalence, risk factors, clinical presentations (categories), prevention, and treatment. ![]() 10 With the speculation that half of the world population will be myopic in 2050 1, it is conceivable that this financial burden will worsen in the near future. reported the global productivity loss caused by MM to be $6 billion. MM poses a tremendous burden to patients, their families, and society. 9 It is estimated that, without changing the current interventions, up to 55.7 million people will have visual impairment, and up to 18.5 million people will be blind, due to MM in 2050. reported that in 2015 MM caused visual impairment in 10 million people and blindness in 3.3 million people worldwide. Myopic maculopathy (MM), also known as myopic macular degeneration, is the most serious, irreversible, vision-threatening complication and the leading cause of bilateral visual impairment and blindness. As a result, the World Health Organization recognizes that myopia, if not fully corrected, is a significant cause of visual impairment. 1 Myopia can cause a wide spectrum of complications, such as cataracts, glaucoma, retinal detachment, and myopia maculopathy. It has been estimated that 50 percent of the world population will be myopic in 2050, with 10 percent having high myopia. Myopia is currently a major public health concern because of its rapidly increasing prevalence worldwide and the threat to vision.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |